+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Occupational Medicines Market by Application, and Industry - Global Opportunity Analysis and Industry Forecast, 2018-2025

  • ID: 4612822
  • Report
  • July 2018
  • Region: Global
  • 220 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • AbbVie, Inc.
  • AstraZeneca
  • Eli Lilly and Company
  • GlaxoSmithKline plc.
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • MORE
Occupational medicines are drugs used to treat patients with work-related diseases and illnesses. The global occupational medicines market was valued at $3,753 million in 2017, and is estimated to reach at $5,794 million by 2025, registering a CAGR of 5.5% from 2018 to 2025.

Rapid increase in the aging workforce and a favorable regulatory environment toward occupational medicines supplement the growth of the market. Furthermore, rise in awareness about occupational health is one of the significant factors that drives the market growth.

However, surge in incorporation of automation and artificial intelligence (AI) at the workplace, emergence of small businesses, and change in industry structure are some of the factors that impede the market growth. Conversely, high potential of emerging economies and increase in demand for occupational medicines are expected to provide new opportunities for the market players during the forecast period.

The global occupational medicines market is segmented based on application, industry, and region. On the basis of application, the market is divided into chemical poisoning, psychological disorder, non-induced hearing loss & vibration, skin disorder, chronic respiratory disease, pneumoconiosis, musculoskeletal disorder, cancer, and other applications.

By industry, it is categorized into agriculture & forestry, construction, manufacturing, petroleum & mining, transportation, and others. Region-wise, it is analyzed across the North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis of the overall market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of the global occupational medicines market.
Market size and estimations are based on comprehensive analysis of the applications and developments in the industry.
An in-depth analysis based on region is provided to understand the regional market and facilitate the strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By application

Chemical poisoning
Psychological disorder
Non-Induced hearing loss & vibration
Skin disorder
Chronic respiratory disease
Pneumoconiosis
Musculoskeletal disorder
Cancer
Others

By industry

Agriculture & forestry
Construction
Manufacturing
Petroleum & mining
Transportation
Others

By region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

The list of key players operating in this market includes:

Johnson & Johnson
Pfizer, Inc.
Eli Lilly and Company
Galderma Laboratories, L.P.
Novartis International AG
Bristol-Myers Squibb
F. Hoffmann-La Roche
Amgen, Inc.
AstraZeneca
Sanofi SA

The OTHER PLAYERS included in the value chain analysis (and not included in the report) include:

Merck & Co., Inc.
AbbVie, Inc.
GlaxoSmithKline plc.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie, Inc.
  • AstraZeneca
  • Eli Lilly and Company
  • GlaxoSmithKline plc.
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • MORE
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top player positioning, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in awareness about occupational health
3.4.1.2. Favorable regulatory environment
3.4.1.3. Rapid increase in aging workforce
3.4.2. Restraints
3.4.2.1. Emergence of small businesses and change in industry structure
3.4.2.2. Rise in incorporation of artificial intelligence (AI) and automation in the industry
3.4.3. Opportunity
3.4.3.1. Untapped potential of the emerging economies

CHAPTER 4: OCCUPATIONAL MEDICINES MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Chemical poisoning
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Psychological disorder
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Non-induced hearing loss & vibration
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Skin disorder
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Chronic respiratory disease
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. Pneumoconiosis
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
4.8. Musculoskeletal disorder
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market analysis, by country
4.9. Cancer
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market analysis, by country
4.10. Others
4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast, by region
4.10.3. Market analysis, by country

CHAPTER 5: OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY
5.1. Overview
5.1.1. Market size and forecast
5.2. Agriculture & forestry
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Construction
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Manufacturing
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Petroleum & mining
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Transportation
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
5.7. Other industries
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country

CHAPTER 6: OCCUPATIONAL MEDICINES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America occupational medicines market size and forecast, by country
6.2.2.1. U.S. market size and forecast
6.2.2.1.1. U.S. occupational medicines market, by industry
6.2.2.1.2. U.S. occupational medicines market, by application
6.2.2.2. Canada market size and forecast
6.2.2.2.1. Canada occupational medicines market, by industry
6.2.2.2.2. Canada occupational medicines market, by application
6.2.2.3. Mexico market size and forecast
6.2.2.3.1. Mexico occupational medicines market, by industry
6.2.2.3.2. Mexico occupational medicines market, by application
6.2.3. North America occupational medicines market size and forecast, by application
6.2.4. North America occupational medicines market size and forecast, by industry
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Europe occupational medicines market size and forecast, by country
6.3.2.1. Germany market size and forecast
6.3.2.1.1. Germany occupational medicines market, by industry
6.3.2.1.2. Germany occupational medicines market, by application
6.3.2.2. France market size and forecast
6.3.2.2.1. France occupational medicines market, by industry
6.3.2.2.2. France occupational medicines market, by application
6.3.2.3. UK market size and forecast
6.3.2.3.1. UK occupational medicines market, by industry
6.3.2.3.2. UK occupational medicines market, by application
6.3.2.4. Italy market size and forecast
6.3.2.4.1. Italy occupational medicines market, by industry
6.3.2.4.2. Italy occupational medicines market, by application
6.3.2.5. Spain market size and forecast
6.3.2.5.1. Spain occupational medicines market, by industry
6.3.2.5.2. Spain occupational medicines market, by application
6.3.2.6. Rest of Europe market size and forecast
6.3.2.6.1. Rest of Europe occupational medicines market, by industry
6.3.2.6.2. Rest of Europe occupational medicines market, by application
6.3.3. Europe occupational medicines market size and forecast, by application
6.3.4. Europe occupational medicines market size and forecast, by industry
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Asia-Pacific occupational medicines market size and forecast, by country
6.4.2.1. Japan market size and forecast
6.4.2.1.1. Japan occupational medicines market, by industry
6.4.2.1.2. Japan occupational medicines market, by application
6.4.2.2. China market size and forecast
6.4.2.2.1. China occupational medicines market, by industry
6.4.2.2.2. China occupational medicines market, by application
6.4.2.3. India market size and forecast
6.4.2.3.1. India occupational medicines market, by industry
6.4.2.3.2. India occupational medicines market, by application
6.4.2.4. Australia market size and forecast
6.4.2.4.1. Australia occupational medicines market, by industry
6.4.2.4.2. Australia occupational medicines market, by application
6.4.2.5. South Korea market size and forecast
6.4.2.5.1. South Korea occupational medicines market, by industry
6.4.2.5.2. South Korea occupational medicines market, by application
6.4.2.6. Rest of Asia-Pacific market size and forecast
6.4.2.6.1. Rest of Asia-Pacific occupational medicines market, by industry
6.4.2.6.2. Rest of Asia-Pacific occupational medicines market, by application
6.4.3. Asia-Pacific occupational medicines market size and forecast, by application
6.4.4. Asia-Pacific occupational medicines market size and forecast, by industry
6.5. LAMEA
6.5.1. Key market trends
6.5.2. LAMEA occupational medicines market size and forecast, by country
6.5.2.1. Brazil market size and forecast
6.5.2.1.1. Brazil occupational medicines market, by industry
6.5.2.1.2. Brazil occupational medicines market, by application
6.5.2.2. Saudi Arabia market size and forecast
6.5.2.2.1. Saudi Arabia occupational medicines market, by industry
6.5.2.2.2. Saudi Arabia occupational medicines market, by application
6.5.2.3. South Africa market size and forecast
6.5.2.3.1. South Africa occupational medicines market, by industry
6.5.2.3.2. South Africa occupational medicines market, by application
6.5.2.4. Rest of LAMEA market size and forecast
6.5.2.4.1. Rest of LAMEA occupational medicines market, by industry
6.5.2.4.2. Rest of LAMEA occupational medicines market, by application
6.5.3. LAMEA occupational medicines market size and forecast, by application
6.5.4. LAMEA occupational medicines market size and forecast, by industry

CHAPTER 7: COMPANY PROFILES
7.1. Amgen Inc.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. AstraZeneca PLC
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. Bristol-Myers Squibb Company
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Eli Lilly and Company
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.5. F. Hoffmann-La Roche Ltd.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. Johnson & Johnson
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product Portfolio
7.6.5.
7.6.6. Business performance
7.6.7. Key strategic moves and developments
7.7. Nestl S.A. (Galderma S.A.)
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product Portfolio
7.7.5.
7.7.6. Business performance
7.7.7. Key strategic moves and developments
7.8. Novartis AG
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product Portfolio
7.8.5. Business performance
7.9. Pfizer Inc.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5.
7.9.6. Business performance
7.10. Sanofi
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product Portfolio
7.10.5.
7.10.6. Business performance
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AbbVie, Inc.
  • AstraZeneca
  • Eli Lilly and Company
  • GlaxoSmithKline plc.
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • MORE
According to a new report, titled, "Occupatiol Medicines Market by Application and Industry: Global Opportunity Analysis and Industry Forecast, 2018-2025, the market was valued at $3,753 million in 2017, and is projected to reach $5,794 million by 2025, growing at a CAGR of 5.5% from 2018 to 2025. Europe is anticipated to be the highest revenue contributor throughout the forecast period.

Occupatiol medicine is a branch of medicine concerned with treatment of work-related diseases; for instance, exposure to second-hand smoke and cancer-causing chemicals in the petroleum & mining industry workers is the cause of diseases, such as chronic obstructive pulmory disease (COPD), skin infections, muscle pains, chemical poisoning, cancer, and others.

The global occupatiol medicine market is expected to grow considerably during the forecast period, owing to various factors, such as rise in awareness related to occupatiol health, rapid growth in geriatric workforce, and favorable regulatory environment towards occupatiol medicine. However, increasing adoption of automation and artificial intelligence (AI) in industries and emerging small businesses along with change in industry structure are the key factors that are expected to hinder the market growth. On the contrary, emerging markets, such as Chi and India, are anticipated to provide lucrative growth opportunities to the market players during the forecast period.

By application, the musculoskeletal disorder segment accounted for one-third share of the global occupatiol medicines market in 2017. Furthermore, the construction segment is anticipated to grow at the highest rate of 7.3% during the forecast period.

Key Findings of the Occupatiol Medicines Market:

North America occupied almost one-fourth share of the global occupatiol medicine market.
The construction segment is anticipated to grow with the highest CAGR throughout the forecast period.
Europe is anticipated to occupy almost two-fifths market share of the global occupatiol medicine market by 2025.
The Asia-Pacific region is anticipated to grow at the highest rate during the forecast period, followed by LAMEA.

Europe was the leading revenue contributor to the global occupatiol medicines market in 2017, owing to European regulatory framework for occupatiol medicines and occupatiol health that insists greatly on monitoring health and safety of workers in the work environment. However, the Asia-Pacific region is expected to grow at the highest CAGR of 7.4% from 2018 to 2025, owing to increase in disposable income, surge in research, development, and innovation activities, and rise in awareness towards occupatiol health.

The report provides an extensive competitive Analysis and profiles of the key market players, such as Amgen, Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Nestl S.A. (Galderma S.A.), Novartis AG, Pfizer, Inc., and Sanofi. The other players in the value chain (not included in the report) include Merck & Co., Inc., AbbVie, Inc., and GlaxoSmithKline plc.
Note: Product cover images may vary from those shown
5 of 5
  • Johnson & Johnson
  • Pfizer, Inc.
  • Eli Lilly and Company
  • Galderma Laboratories, L.P.
  • Novartis International AG
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Amgen, Inc.
  • AstraZeneca
  • Sanofi SA
  • Merck & Co., Inc.
  • AbbVie, Inc.
  • GlaxoSmithKline plc.
Note: Product cover images may vary from those shown
6 of 5

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll